Answers are grounded in this paper and cite their sources.
A key constraint to successfully commercializing beneficial microorganisms is overcoming difficulties in formulating a viable, cost‐effective, and user‐friendly final product. The live nature of the active ingredient (i.e., the microbial agent) underscores the importance of formulation in maintaining the microbial cells in a metabolically and physiologically competent state in order to obtain the desired benefit when applied. The development of new microbial formulations is a challenging task and requires greater effort in terms of funding and research towards making significant advances in this field.
No takes yet. Share an insight, caveat, or question.
Xavier et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: